Don’t Jump to Caplyta or Secuado for Schizophrenia
Caplyta (kah-PLY-tah, lumateperone) and Secuado (seh-KWAH-doh, asenapine) will be two new atypical antipsychotics.
There are now over a dozen of these second-generation options...with varying activity at receptors (dopamine, serotonin, etc).
But efficacy seems similar.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote